System-based proteomic and metabonomic analysis of the Df (16) A+/− mouse identifies potential miR-185 targets and molecular pathway alterations

H Wesseling, B Xu, EJ Want, E Holmes, PC Guest… - Molecular …, 2017 - nature.com
Abstract Deletions on chromosome 22q11. 2 are a strong genetic risk factor for development
of schizophrenia and cognitive dysfunction. We employed shotgun liquid chromatography …

Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11. 2 deletion syndrome

M Zafarullah, K Angkustsiri, A Quach, S Yeo… - Metabolomics, 2024 - Springer
Abstract Introduction The chromosome 22q11. 2 deletion syndrome (22q11. 2DS) is
characterized by a well-defined microdeletion and is associated with a wide range of brain …

Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome

E Sefik, RH Purcell, EF Walker, GJ Bassell… - Translational …, 2021 - nature.com
Abstract The 3q29 deletion (3q29Del) confers high risk for schizophrenia and other
neurodevelopmental and psychiatric disorders. However, no single gene in this interval is …

Df (h15q13)/+ mouse model reveals loss of astrocytes and synaptic-related changes of the excitatory and inhibitory circuits in the medial prefrontal cortex

AR Al-Absi, P Qvist, S Glerup, C Sanchez… - Cerebral …, 2021 - academic.oup.com
Abstract The 15q13. 3 deletion is associated with multiple neurodevelopmental disorders
including epilepsy, schizophrenia, and autism. The Df (h15q13)/+ mouse model was …

Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11. 2 deletion syndrome and schizophrenia

S Sivagnanasundaram, D Fletcher, M Hubank… - Brain research, 2007 - Elsevier
Genes and a 3-Mb deletion mapping to human chromosome 22q11. 2 have been implicated
in 22q11. 2 deletion syndrome (22q11. 2DS) and schizophrenia. The Df1 heterozygous …

Neuroanatomical phenotypes in a mouse model of the 22q11. 2 microdeletion

J Ellegood, S Markx, JP Lerch, PE Steadman… - Molecular …, 2014 - nature.com
Recurrent deletions at the 22q11. 2 locus have been established as a strong genetic risk
factor for the development of schizophrenia and cognitive dysfunction. Individuals with …

Transcriptome profiling of peripheral blood in 22q11. 2 deletion syndrome reveals functional pathways related to psychosis and autism spectrum disorder

M Jalbrzikowski, MT Lazaro, F Gao, A Huang, C Chow… - PloS one, 2015 - journals.plos.org
Background 22q11. 2 Deletion Syndrome (22q11DS) represents one of the greatest known
genetic risk factors for the development of psychotic illness, and is also associated with high …

MicroRNAs as the cause of schizophrenia in 22q11. 2 deletion carriers, and possible implications for idiopathic disease: a mini-review

AJ Forstner, F Degenhardt, G Schratt… - Frontiers in molecular …, 2013 - frontiersin.org
The 22q11. 2 deletion is the strongest known genetic risk factor for schizophrenia. Research
has implicated microRNA-mediated dysregulation in 22q11. 2 deletion syndrome (22q11 …

Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome

NJM van Beveren, LC Krab, S Swagemakers… - PLoS …, 2012 - journals.plos.org
22q11 Deletion Syndrome (22q11DS) is associated with dysmorphology and a high
prevalence of schizophrenia-like symptoms. Several genes located on chromosome 22q11 …

MicroRNA dysregulation, gene networks, and risk for schizophrenia in 22q11. 2 deletion syndrome

D Merico, G Costain, NJ Butcher, W Warnica… - Frontiers in …, 2014 - frontiersin.org
The role of microRNAs (miRNAs) in the etiology of schizophrenia is increasingly recognized.
Microdeletions at chromosome 22q11. 2 are recurrent structural variants that impart a high …